Hefter, Harald http://orcid.org/0000-0003-1069-7684
Ürer, Beyza
Brauns, Raphaela
Rosenthal, Dietmar
Meuth, Sven G.
Lee, John-Ih
Albrecht, Philipp
Samadzadeh, Sara
Funding for this research was provided by:
Universitätsklinikum Düsseldorf. Anstalt öffentlichen Rechts
Article History
Received: 23 November 2021
Revised: 20 April 2022
Accepted: 16 June 2022
First Online: 17 July 2022
Declarations
:
: Dr. Dietmar Rosenthal, Dr. Sara Samadzadeh, Dr Beyza Ürer, and Dr. Raphaela Brauns have nothing to declare, Prof. Harald Hefter is a consultant and speaker for Merz, Ipsen, and Allergan. This study has been supported by a restricted grant of the Inge-Diesbach Stiftung to prof. Harald Hefter. This grant did not have influence on the design and content of the present study. He declares no other disclosures relevant for the manuscript. Sven G Meuth has received honoraria for lecturing and travel expenses for attending meetings from Almirall, Amicus Therapeutics Germany, Bayer Health Care, Biogen, Celgene, Diamed, Genzyme, MedDay Pharmaceuticals, Merck Serono, Novartis, Novo Nordisk, ONO Pharma, Roche, Sanofi-Aventis, Chugai Pharma, QuintilesIMS, and Teva. His research is funded by the German Ministry for Education and Research (BMBF), Deutsche Forschungsgemeinschaft (DFG), Else Kröner Fresenius Foundation, German Academic Exchange Service, Hertie Foundation, Interdisciplinary Center for Clinical Studies (IZKF) Muenster, German Foundation Neurology, and by Almirall, Amicus Therapeutics Germany, Biogen, Diamed, Fresenius Medical Care, Genzyme, Merck Serono, Novartis, ONO Pharma, Roche, and Teva. John-Ih Lee has received honoraria for speaking/consultation from Bayer Healthcare, Boehringer Ingelheim, Allergan, Novartis, Ipsen, Teva, and Daiichi-Sankyo, as well as travel grants from Bayer Healthcare, Merz, Allergan, and Ipsen, outside the submitted work. Philipp Albrecht received a research grant form Ipsen Pharma to support the analysis of the data of patients with spasticity and a grant from Merz Pharmaceuticals for funding of NAB-testing. Besides this, he reports grants, personal fees and non-financial support from Allergan, Biogen, Ipsen, Merz Pharmaceuticals, Merck, Novartis, and Roche, personal fees and non-financial support from Bayer Healthcare, and non-financial support from Sanofi-Aventis/Genzyme, outside the submitted work.
: The local ethics committee of the University of Düsseldorf allows publication of anonymized clinical data retrospectively extracted from patients’ charts.
: All participants gave informed consent to participate in all studies run by University Hospital. Duesseldorf. And they also gave informed consent for publication any research work from their data.